Strongyloides stercoralis hyperinfection after corticosteroid therapy: A report of two cases

Annals of Saudi Medicine

Volumn 29, Issue 5, 2009, Pages 397-401

  Al Maslamani, Mona A ^a   Al Soub, Hussam A ^a   Al Khal, Abdel Latif M ^a   Al Bozom, Issam A ^a   Abu Khattab, Mohammed J ^a   Chacko, Kadavil C ^a  

^a HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALBENDAZOLE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; CORTICOSTEROID; DEXAMETHASONE; ETHAMBUTOL; FLUTICASONE; IPRATROPIUM BROMIDE; ISONIAZID; IVERMECTIN; METHYLPREDNISOLONE; OXYGEN; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; SALBUTAMOL; SALMETEROL; THEOPHYLLINE;

ABDOMINAL RADIOGRAPHY; ACUTE ABDOMEN; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSISTED VENTILATION; BLOOD ANALYSIS; BRAIN HEMORRHAGE; BRONCHUS BIOPSY; CANCER RADIOTHERAPY; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; COUGHING; DEATH; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EARLY DIAGNOSIS; EARLY INTERVENTION; FEVER; HERPES ZOSTER; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; INDIA; INTESTINE DISTENSION; INTESTINE OBSTRUCTION; LAPAROTOMY; LUNG DISEASE; MALE; MORTALITY; MULTIPLE MYELOMA; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SPINAL CORD COMPRESSION; SPUTUM CULTURE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; THORAX RADIOGRAPHY; VARICELLA ZOSTER VIRUS;

ADULT; ANIMALS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES; MALE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 70350580670     PISSN: 02564947     EISSN: 13199226     Source Type: Journal    
DOI: 10.4103/0256-4947.55172     Document Type: Article

References (21)

1. Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insights in to the prevention of disseminated disease. Rev Infect Dis 1989;11:755-767
2. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001;33:1040-1047
3. Cruz T, Reboucas G, Rocha H. Fatal strongyloidiasis in patients receiving Corticosteroids. N Engl J Med 1966;275:1093-1096
4. Keiser PB, Nutman TB: Strongyloides stercoralis in the Immunocompromised Population. Clin Microbiol Rev 2004;17:208-217
5. DeVault GA Jr, King JW, Rohr MS, Landreneau MD, Brown ST 3rd, McDonald JC. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis 1990;12:653-671
6. Rogers WA Jr, Nelson B. Strongyloidiasis and malignant lymphoma: "Opportunistic infection" by a nematode. JAMA 1966;195:685-687
7. Berk SL, Verghese A, Alvaresz S, Hall K, Smith B. Clinical and epidemiologic features of strongyloidiasis: A prospective study in rural Tennessee. Arch Intern Med 1987;147:1257-1261 (Pubitemid 17102153)
8. Wehner JH, Kirsh CM. Pulmonary manifestation of strongyloidiasis. Semin Respir Infect 1997;12:122-129
9. Debussche X, Toublanc M, Camillieri JP, Assan R. Overwhelming strongyloidiasis in a diabetic patient following adrenocorticotropin treatment and keto-acidosis. Diabetes Metab 1988;14:294-298 (Pubitemid 18159986)
10. Rivera E, Maldonado N, Vélez-García E, Grillo AJ, Malaret G. Hyperinfection syndrome with Strongyloides stercoralis. Ann Intern Med 1970;72:199-204.
11. Link K, Orenstein R. Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis. South Med J 1999;92:728-731
12. Uparanukraw P, Phongsri S, Morakote N. Fluctuations of larval excretion in Strongyloides stercoralis infection. Am J Trop Med Hyg 1999;60:967-973
13. Gutierra Y. Diagnostic pathology of parasitic infections with clinical correlations. 2nd ed. Oxford: Oxford University Press; 2000.
14. Siddiqui AA, Koenig NM, Sinensky M, Berk SL. Strongyloides stercoralis: identification of antigens in natural human infections from endemic areas of the United States. Parasitol Res 1997;83:655-668 (Pubitemid 27364415)
15. Pitisuttithum P, Supanaranond W, Chindanond D. A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. Southeast Asian J Trop Med Public Health 1995;26:735-738
16. Gann PH, Neva FA, Gam AA. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 1994;169:1076-1079
17. Shikiya K, Zaha O, Niimura S, Uehara T, Ohshiro J, Kinjo F, et al. Clinical study on ivermectin against 125 strongyloidiasis patients. Kansenshogaku Zasshi 1994;68:13-20.
18. Dreyer G, Fernandes-Silva E, Alves S, Rocha A, Albuquerque R, Addiss D. Patterns of detection of Strongyloides stercoralis in stool specimens: implications for diagnosis and clinical trials. J Clin Microbiol 1996;34: 2569-2571 (Pubitemid 26307813)
19. Said T, Nampoory MR, Nair MP, Halim MA, Shetty SA, Kumar AV, et al. Hyperinfection strongyloidiasis: an anticipated outbreak in kidney transplant recipients in Kuwait. Transplant Proc 2007;39:1014-1015 (Pubitemid 46764886)
20. Uwaydah AK, Al Qadah F. Strongyloides stercoralis hyperinfection in a patient with angioimmunoblastic lymphadenopathy. Postgrad Med J 1992;68:974-975
21. Gill GV, Bell DR. Strongyloides stercoralis infection in former Far East prisoners of war. Br Med J Clin Res 1979;2:572-574